Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giselle Dutcher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cureus|November 4, 2020
Unusual Presentation of Renal Medullary Carcinoma With Undiagnosed Sickle Cell TraitFahmin Basher, Giselle Dutcher, Jonathan S England, et al.
International Journal of Molecular Sciences|August 26, 2022
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung CancerMisty Dawn Shields, Kevin Chen, Giselle Dutcher, et al.
Current Oncology (Toronto, Ont.)|May 27, 2025
Drug Sensitivity Testing in Osteosarcoma: A Case ReportInes Lohse, Giselle Dutcher, Hassan Al-Ali, et al.
Cancers|October 14, 2022
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant WaveSamuel A Kareff, Aliya Khan, Priscila Barreto-Coelho, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cureus|November 4, 2020
Unusual Presentation of Renal Medullary Carcinoma With Undiagnosed Sickle Cell TraitFahmin Basher, Giselle Dutcher, Jonathan S England, et al.
International Journal of Molecular Sciences|August 26, 2022
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung CancerMisty Dawn Shields, Kevin Chen, Giselle Dutcher, et al.
Current Oncology (Toronto, Ont.)|May 27, 2025
Drug Sensitivity Testing in Osteosarcoma: A Case ReportInes Lohse, Giselle Dutcher, Hassan Al-Ali, et al.
Cancers|October 14, 2022
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant WaveSamuel A Kareff, Aliya Khan, Priscila Barreto-Coelho, et al.
Pageof 1